Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Protection certificate |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 12 2019 000 051.8 |
| Use | VZ | Medicinal products |
95 | Product name | TIEZ | Everolimus oder ein pharmazeutisch annehmbares Salz davon |
54 | Title of basic patent | TIGZ | EIN RAPAMYCINDERIVAT ZUR BEHANDLUNG VON LUNGENKREBS |
51 | IPC main class | ICM (ICMV) | A61K 31/436 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61P 35/00 (2006.01) |
94 | Start of term of protection | LB | Feb 19, 2022 |
22 | DE application date | DAT | Jun 3, 2019 |
| Date of publication of application for a certificate | OT | Sep 5, 2019 |
71/73 | Applicant/owner | INH | Novartis Pharma AG, Basel, CH |
74 | Representative | VTR | Breuer Friedrich Hahner Patentanwälte PartG mbB, 80333 München, DE |
| Address for service | | Breuer Friedrich Hahner Patentanwälte PartG mbB, 80333 München, DE |
| Patent division in charge | | 44 |
68 | DE file number of basic patent | GAKZ | 602 49 722.1 |
68 | EP file number of basic patent | GEAKZ | 16 18 6041.6 |
43 | Date of first publication | EVT | Sep 5, 2019 |
92 92 92
| Domestic authorisation | GIS GIN GIT
| Europäische Kommission EU/1/09/538/009 2016-05-26
|
92 92 92
| Domestic authorisation | GIS GIN GIT
| Europäische Kommission EU/1/09/538/007 2016-05-26
|
92 92 92
| Domestic authorisation | GIS GIN GIT
| Europäische Kommission EU/1/09/538/008 2016-05-26
|
92 92 92
| Domestic authorisation | GIS GIN GIT
| Europäische Kommission EU/1/09/538/001 2016-05-26
|
92 92 92
| Domestic authorisation | GIS GIN GIT
| Europäische Kommission EU/1/09/538/006 2016-05-26
|
92 92 92
| Domestic authorisation | GIS GIN GIT
| Europäische Kommission EU/1/09/538/004 2016-05-26
|
92 92 92
| Domestic authorisation | GIS GIN GIT
| Europäische Kommission EU/1/09/538/003 2016-05-26
|
92 92 92
| Domestic authorisation | GIS GIN GIT
| Europäische Kommission EU/1/09/538/010 2016-05-26
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| Europäische Kommission EU EU/1/09/538/001 2016-05-26
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| Europäische Kommission EU EU/1/09/538/008 2016-05-26
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| Europäische Kommission EU EU/1/09/538/003 2016-05-26
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| Europäische Kommission EU EU/1/09/538/007 2016-05-26
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| Europäische Kommission EU EU/1/09/538/009 2016-05-26
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| Europäische Kommission EU EU/1/09/538/006 2016-05-26
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| Europäische Kommission EU EU/1/09/538/010 2016-05-26
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| Europäische Kommission EU EU/1/09/538/004 2016-05-26
|
| Date of the first transfer into DPMAregister | EREGT | Sep 5, 2019 |
| Date of the (most recent) update in DPMAregister | REGT | Aug 9, 2024 (Show all update days)(Hide all update days)- Aug 9, 2024
- Procedures: New representative details, New representative details, 24.06.2020: changed
- Procedures: New representative details, New representative details, 05.09.2019: changed
- Apr 30, 2022; Oct 13, 2020; Sep 24, 2020; Jun 25, 2020; Sep 6, 2019
- Historical data not available for this/these date(s)
- Sep 5, 2019
- Date of the first transfer into DPMAregister
|
View procedures New representative details (No.: 2)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New representative details |
| Legal/procedural status | VST | New representative details |
| Date of legal/procedural status | VSTT | Sep 5, 2019 |
74 | Representative | VTR | Breuer, Markus, Dr., 80331 München, DE |
74 | Previous representative | VTRF | Henkel, Breuer & Partner, 80333 München, DE |
| Date of update of the procedure | REGT | Aug 9, 2024 |